Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis

NCT03883360 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped not funded

Conditions

Schizophrenia Spectrum Disorders
Cannabis Use

Interventions

DRUG: Cannabidiol (CBD)
DRUG: Placebo

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]
[object Object]